Clobazam is a 1,5-benzodiazepine GABA-A positive allosteric modulator used as adjunctive therapy for Lennox-Gastaut syndrome and other difficult-to-treat epilepsy syndromes. Simson Pharma's Clobazam reference standard and impurities support compendial and controlled-substance-aligned testing for this antiepileptic benzodiazepine.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clobazam Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.